L. Méthodes-chamas and R. Nussbaum, The Metabolic Basis of Inherited Disease, pp.3705-3716, 1995.

R. Choudhury, A. Diao, F. Zhang, E. Eisenberg, A. Saint-pol et al., Lowe syndrome protein OCRLl interacts with clathrin and regulates protein trafficking between endosomes and the

R. Choudhury, C. Noakes, E. Mckenzie, C. Kox, and M. Lowe, Differential Clathrin Binding and Subcellular Localization of OCRL1 Splice Isoforms, Journal of Biological Chemistry, vol.284, issue.15, pp.9965-73, 2009.
DOI : 10.1074/jbc.M807442200

G. Cibis, J. Waeltennann, C. Whitcraft, R. Tripathi, and D. Harris, Lenticular Opacities in Carriers of Lowe's Syndrome, Ophthalmology, vol.93, issue.8, pp.1041-1046, 1986.
DOI : 10.1016/S0161-6420(86)33623-6

E. -dequeker, S. Ramsden, W. Grody, T. Stenzel, and D. Barton, Quality control in molecular genetic testing, Nature Reviews Genetics, vol.2, issue.9, pp.717-740, 2001.
DOI : 10.1038/35088588

C. Dent and M. Friedman, Hypercalciuric rickets associted with Tenal tubular damage, 1964.

-. Paolo, G. , D. Camilli, and P. , Phosphoinositides in cell regulation and membrane dynamics, Nature, vol.26, issue.7112, pp.651-658, 2006.
DOI : 10.1038/nature05185

J. Schouten, Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways, Nucleic Acids Res, vol.1, pp.31-153, 2003.

K. -erdmann, Y. Mao, H. Mccrea, R. Zoncu, S. Lee et al., A Role of the Lowe Syndrome Protein OCRL in Early Steps of the Endocytic Pathway, Developmental Cell, vol.13, issue.3, pp.377-90, 2007.
DOI : 10.1016/j.devcel.2007.08.004

A. -faucherre, P. Desbois, V. Satre, and J. Lunardi, Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network, Human Molecular Genetics, vol.12, issue.19, pp.2449-56, 2003.
DOI : 10.1093/hmg/ddg250

R. Gardner and N. Brown, Lowe's syndrome: identification of carriers by lens examination., Journal of Medical Genetics, vol.13, issue.6, pp.449-54
DOI : 10.1136/jmg.13.6.449

B. -goud, How Rab proteins link motors to membranes, Nature Cell Biology, vol.4, issue.4, pp.77-85, 2005.
DOI : 10.1038/ncb0402-e77

B. Goud, Communication personnelle, 2005.

P. Giordano, Nine unk:nown rearrangements in 16p13.3 and 1 lp15.4 causing alpha-and beta thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification, J Med Genet, vol.42, pp.922-953, 2005.

J. Schouten, C. Meijer, P. Snijders, and R. Steenbergen, Br Sequential gene promoter methylation during HPV-induced cervical carcinogenesis, J Cancer, vol.97, pp.1457-64, 2009.

S. Zeinali, Validation and comparison of two quantitative real-time PCR assays for direct detection of DMD/BMD carriers, Clin Biochem, 2009.

C. Hess, F. Denkers, G. Ossenkoppele, Q. Waisfisz, C. Mcelgunn et al., Gene expression profiling of minimal residual disease in acute myeloid leukaemia by novel multiplex-PCR-based method, Leukemia, vol.18, issue.12, pp.1981-1989, 2004.
DOI : 10.1038/sj.leu.2403520

S. Hodgson, J. Heckmatt, E. Hughes, J. Crolla, V. Dubowitz et al., A balanced de novo X/autosome translocation in a girl with manifestations of lowe syndrome, American Journal of Medical Genetics, vol.18, issue.3, 1986.
DOI : 10.1002/ajmg.1320230311

F. Hogervorst, P. Nederlof, and J. Gille, Large genomic deletions and duplications in the BRCAl gene identified by a novel quantitative method, Cancer Res, vol.63, pp.1449-53, 2003.

C. -hollennan and C. , Aminoaciduria-renal transport, Am J Dis Child, vol.115, pp.169-178, 1968.

R. Hoopes, . Ir, A. Shrimpton, S. Knohl, P. Hueber et al., Dent Disease with mutations in OCRLl, Am J Hum Genet. Am J Hum Genet, vol.7681, issue.2, pp.260-7634, 2005.

N. Hyvola, A. Diao, E. Mckenzie, A. Skippen, S. Cockcroft et al., Membrane targeting and activation of the Lowe syndrome protein OCRLl by rab GTPases, EMBO J, vol.253750, p.61, 2006.

B. -janssen, C. Hartmann, V. Scholz, A. Jauch, and J. Zschocke, MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls, Neurogenetics, vol.11, issue.1, pp.29-35, 2005.
DOI : 10.1007/s10048-004-0204-1

M. -jeanpierre, A rapid method for the purification of DNA from blood, Nucleic Acids Research, vol.15, issue.22, p.9611, 1987.
DOI : 10.1093/nar/15.22.9611

J. -jeuken, S. Comelissen, M. Vriezen, M. Dekkers, A. Errami et al., MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas, Laboratory Investigation, vol.349, issue.10, pp.1055-65, 2007.
DOI : 10.1038/labinvest.3700664

L. Kenworthy, T. Park, and L. Chamas, Cognitive and behavioral profile of the oculocerebrorenal syndrome of Lowe, American Journal of Medical Genetics, vol.19, issue.3, pp.297-303
DOI : 10.1002/ajmg.1320460312

L. Kenworthy and L. Chamas, Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of lowe, American Journal of Medical Genetics, vol.92, issue.3, pp.283-290, 1995.
DOI : 10.1002/ajmg.1320590304

P. Kozlowski, P. Roberts, S. Dabora, D. Franz, J. Bissler et al., Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations, Human Genetics, vol.45, issue.3-4, pp.389-400, 2007.
DOI : 10.1007/s00439-006-0308-9

P. Kozlowski, A. Jasinska, and D. Kwiatkowski, New applications and developments in the use of multiplex ligation-dependent probe amplification, ELECTROPHORESIS, vol.40, issue.23, pp.4627-4663, 2008.
DOI : 10.1002/elps.200800126

K. Lai, I. Lo, T. Tong, L. Cheng, and S. Lam, Detecting exon deletions and duplications of the DMD gene using Multiplex Ligation-dependent Probe Amplification (MLPA), Clinical Biochemistry, vol.39, issue.4, pp.367-72, 2006.
DOI : 10.1016/j.clinbiochem.2005.11.019

A. Leahey, L. Chamas, and R. Nussbaum, gene in patients with the oculocerebrorenal syndrome of Lowe, Human Molecular Genetics, vol.2, issue.4, pp.461-464, 1993.
DOI : 10.1093/hmg/2.4.461

U. Lichter-konecki, L. Farber, J. Cronin, S. Suchy, and R. Nussbaum, The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function, Molecular Genetics and Metabolism, vol.89, issue.1-2, pp.121-129, 2006.
DOI : 10.1016/j.ymgme.2006.04.005

T. -lin, B. Orrison, S. Suchy, R. Lewis, and R. Nussbaum, Mutations Are Not Uniformly Distributed throughout theOCRL1Gene in Lowe Syndrome Patients, Molecular Genetics and Metabolism, vol.64, issue.1, pp.58-61, 1998.
DOI : 10.1006/mgme.1998.2687

T. -lin, R. Lewis, and R. Nussbaum, Molecular confinnation of carriers for Lowe syndrome

S. Lloyd, S. Pearce, S. Fisher, K. Steinmeyer, B. Schwappach et al., A common molecular basis for three inherited kidney stone diseases, Nature, vol.379, issue.6564, pp.445-449, 1996.
DOI : 10.1038/379445a0

J. -loughead, F. Mimouni, S. Shiling, and B. Wood, Radiological cases of the month. 1992, Am J Dis Child, vol.146, pp.1209-1210

C. -lowe, M. Terrey, and E. Maclachan, Organic aciduria, decreased renal ammonia production, hydrophtalmos, and mental retardation : a clinical entity, Am J Dis Child, vol.83, pp.164-184, 1952.

M. -lowe, Structure and Function of the Lowe Syndrome Protein OCRL1, Traffic, vol.99, issue.Pt 3, pp.711-719, 2005.
DOI : 10.1111/j.1600-0854.2005.00311.x

A. Monaco, C. Bertelson, S. Liechti-gallati, H. Moser, and L. Kunkel, An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus, Genomics, vol.2, issue.1, 1988.
DOI : 10.1016/0888-7543(88)90113-9

K. Mcspadden, Z. Dolinsky, and K. Schroerlucke, Report on the Lowe's syndrome comprehensive survey West Lafayette, 1991.

C. -ménager and K. Kaibuchi, Les protéines Rho: leur rôle dans les neurones Med Sei, pp.358-363, 2003.

N. -monnier, V. Satre, E. Lerouge, F. Berthoin, and J. Lunardi, OCRL1 mutation analysis in French Lowe syndrome patients: Implications for molecular diagnosis strategy and genetic counseling, Human Mutation, vol.16, issue.2, pp.157-65, 2000.
DOI : 10.1002/1098-1004(200008)16:2<157::AID-HUMU8>3.0.CO;2-9

T. Tedesco, Lowe oculocerebrorenal syndrome in a female with a balanced X

R. Nussbaum, B. Orrison, P. Janne, L. Charnas, and A. Chinault, Physical mapping and genomic structure of the Lowe syndrome gene OCRL1, Human Genetics, vol.99, issue.2, pp.145-50, 1997.
DOI : 10.1007/s004390050329

A. Errami, Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences, Nucleic Acids Res, vol.33, p.128, 2005.

I. Olivos-glander, P. Jiinne, and R. Nussbaum, The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex, Am J Hum Genet, vol.57, pp.817-840, 1995.

L. Ooms, K. Horan, P. Rahman, G. Seaton, R. Gurung et al., The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease, Biochemical Journal, vol.419, issue.1
DOI : 10.1042/BJ20081673

J. Peck, G. Douglas, C. Wu, and P. Burbelo, Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships, FEBS Letters, vol.130, issue.1-3, pp.27-34, 2002.
DOI : 10.1016/S0014-5793(02)03331-8

J. Peverall, E. Edkins, J. Goldblatt, and A. Murch, Identification of a novel deletion of the entire OCRL1 gene detected by FISH analysis in a family with Lowe syndrome, Clinical Genetics, vol.57, issue.9, pp.479-82, 2000.
DOI : 10.1034/j.1399-0004.2000.580609.x

C. Ponting, A novel domain suggests a ciliary function for ASPM, a brain size determining gene, Bioinformatics, vol.22, issue.9, pp.1031-1036, 2006.
DOI : 10.1093/bioinformatics/btl022

M. -priolo, A. Sparago, C. Mammi, F. Cerrato, C. Laganà et al., MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment, European Journal of Human Genetics, vol.16, issue.5, pp.565-71, 2008.
DOI : 10.1038/sj.ejhg.5202001

M. Procter, L. Chou, W. Tang, J. M. Mao, and R. , Molecular diagnosis of Prader-Willi and

L. -rooms, E. Reyniers, R. Van-luijk, S. Scheers, J. Wauters et al., Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA), Human Mutation, vol.49, issue.1, pp.17-21, 2004.
DOI : 10.1002/humu.10300

W. -rôschinger, A. Muntau, G. Rudolph, A. Roscher, and S. Kammerer, Carrier Assessment in Families with Lowe Oculocerebrorenal Syndrome: Novel Mutations in the OCRL1 Gene and Correlation of Direct DNA Diagnosis with Ocular Examination, Molecular Genetics and Metabolism, vol.69, issue.3, pp.213-222, 2000.
DOI : 10.1006/mgme.1999.2955

A. Megabarne, H. Philippe, H. Plauchu, M. Torres, and J. Lunardi, Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven navel mutations in the OCRLl gene, Am J Hum Genet, vol.65, pp.68-76, 1999.

V. -satre, Analyse génétique et fonctionnelle du géne OCRLI associé au syndrome de Lowe, Th PhD, 2007.

M. -schuetzle, T. Uphoff, B. Hatten, and D. Dawson, Utility of microsatellite analysis in evaluation of pregnancies with placental mesenchymal dysplasia, Prenatal Diagnosis, vol.10, issue.13, pp.1238-1282, 2007.
DOI : 10.1002/pd.1879

J. -schouten, C. Mcelgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens et al., Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Research, vol.30, issue.12, p.57, 2002.
DOI : 10.1093/nar/gnf056

J. Inatomi and T. Igarashi, OCRLl mutations in patients with Dent disease phenotype in Japan

L. Sellner and G. Taylor, MLPA and MAPH: New techniques for detection of gene deletions, Human Mutation, vol.20, issue.5, pp.413-422, 2004.
DOI : 10.1002/humu.20035

H. Shao, V. Lip, and B. Wu, Effectiveness of multiplex ligation-dependent probe amplification assay used for detecting deletion of Prader-Willi syndrome, Beijing Da Xue Xue Bao, vol.37, pp.64-71, 2005.

D. Silver, R. Lewis, and R. Nussbaum, Mapping the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphisms., Journal of Clinical Investigation, vol.79, issue.1, pp.282-285, 1987.
DOI : 10.1172/JCI112795

S. Suchy, I. Olivos-glander, and R. Nussabaum, Lowe Syndrome, a deficiency of a phosphatidyl-inositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus, Human Molecular Genetics, vol.4, issue.12, pp.2245-50, 1995.
DOI : 10.1093/hmg/4.12.2245

S. Suchy and R. Nussbaum, The Deficiency of PIP2 5-Phosphatase in Lowe Syndrome Affects Actin Polymerization, The American Journal of Human Genetics, vol.71, issue.6, pp.1420-1427, 2002.
DOI : 10.1086/344517

H. Slater, D. Bruno, H. Ren, M. Pertile, J. Schouten et al., Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA), Journal of Medical Genetics, vol.40, issue.12, pp.907-919, 2003.
DOI : 10.1136/jmg.40.12.907

R. Stern, R. Robe1is, K. Mann, S. Yau, J. Berg et al., Multiplex ligation-dependent probe amplification using a completely synthetic probe set, Biotechniques, vol.37, pp.399-405, 2004.

A. Norden and T. Feest, Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance, QJM, vol.87, pp.473-493, 1994.

. Array-mlp, A: comprehensive detection of deletions and duplications and its application to DMD patients, Hum Mutat, vol.29, pp.190-197, 2008.

X. Zhang, A. Jefferson, V. Auethavekiat, and P. Majerus, The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase., Proc Natl Acad Sei U S A, pp.4853-4859, 1995.
DOI : 10.1073/pnas.92.11.4853

J. -zhi and E. Hatchwell, Human MLPA Probe Design (H-MAPD): a probe design tool for both electrophoresis-based and bead-coupled human multiplex ligation-dependent probe amplification assays, BMC Genomics, vol.9, issue.1, p.407, 2008.
DOI : 10.1186/1471-2164-9-407

J. Ntr-length-sequence-85, G. , G. , G. A. Tgttttccgttacttgatggcattcctt-cgagaactcttaa., . Attctctgaatac et al., tttcccttgacttaagttgattcag 128 CTGGCAGCAACCACTCTGTGGCTGAAGCACTGCTCATTTTCTTGGAAGCCCTGCCAGAGC CAGTCATCTGTTACGAGCTGTATCAGCGATGTCTTGACTCTGCTTATGATCCCCGGATCT GCCGACAG 831 gtgggttctactgacctggggatgt, p.406